UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Global H3K4me3 genome mapping reveals alterations of innate immunity signaling and overexpression of JMJD3 in human myelodysplastic syndrome CD34+ cells

Leukemia, 2013-11, Vol.27 (11), p.2177-2186

2013

Volltextzugriff (PDF)

S160: MOLECULAR DETERMINANTS OF DISEASE PROGRESSION AFTER HYPOMETHYLATING AGENT THERAPY IN RAS PATHWAY MUTANT CHRONIC MYELOMONOCYTIC LEUKEMIA AT THE SINGLE‐CELL LEVEL

HemaSphere, 2022-06, Vol.6, p.61-62

2022

Volltextzugriff (PDF)

Toll-like receptor alterations in myelodysplastic syndrome

Leukemia, 2013-09, Vol.27 (9), p.1832-1840

2013

Volltextzugriff (PDF)

Identification of the Specific Hematopoietic Stem Cell Populations Responsible for Failure to Hypomethylating Agents in Myelodysplastic Syndromes

Leukemia research, 2017-04, Vol.55, p.S34-S36

2017

Volltextzugriff (PDF)

PS1325 IDENTIFICATION AND TARGETING OF MOLECULAR SIGNATURES OF HYPOMETHYLATING AGENT RESISTANCE IN MYELODYSPLASTIC SYNDROME AND CHRONIC MYELOMONOCYTIC LEUKEMIA

HemaSphere, 2019-06, Vol.3 (S1), p.605-n/a

2019

Volltextzugriff (PDF)

Deregulation of innate immune and inflammatory signaling in myelodysplastic syndromes

Leukemia, 2015-07, Vol.29 (7), p.1458-1469

2015

Volltextzugriff (PDF)

SINGLE CELL DATA

Leukemia research, 2023-05, Vol.128, p.107084, Article 107084

2023

Volltextzugriff (PDF)

Topic: AS04-MDS Biology and Pathogenesis/AS04d-Somatic mutations

Leukemia research, 2021-09, Vol.108, p.106678, Article 106678.4

2021

Volltextzugriff (PDF)

O04 - Topic: AS04-MDS Biology and Pathogenesis/AS04d-Somatic mutations: SINGLE-CELL-LEVEL ANALYSIS OF SF3B1-MUTANT MYELODYSPLASTIC SYNDROME WITH RINGED SIDEROBLASTS

Leukemia research, 2021-09, Vol.108

2021

Volltextzugriff (PDF)

Mechanisms of resistance to apoptosis in the human acute promyelocytic leukemia cell line NB4

Annals of hematology, 2015-03, Vol.94 (3), p.379-392

2015

Volltextzugriff (PDF)

52 - Identification of the Specific Hematopoietic Stem Cell Populations Responsible for Failure to Hypomethylating Agents in Myelodysplastic Syndromes

Leukemia research, 2017-04, Vol.55, p.S34-S36

2017

Volltextzugriff (PDF)

Changes in mitochondrial function induced by dequalinium precede oxidative stress and apoptosis in the human prostate-cancer cell line PC-3

Molecular biology (New York), 2014-05, Vol.48 (3), p.359-370

2014

Volltextzugriff (PDF)

Changes in mitochondrial function induced by dequalinium precede oxidative stress and apoptosis in the human prostate cancer cell line PC-3

Molekuliarnaia biologiia, 2014-05, Vol.48 (3), p.416

2014

Volltextzugriff (PDF)

Индуцируемые деквалином изменения митохондриальных функций предшествуют окислительному стрессу и апоптозу в линии клеток РС-3 рака предстательной железы человека

Молекулярная биология, 2014, Vol.48 (3), p.416-428

2014

Volltextzugriff (PDF)

Isolation, culture, and immunophenotypic analysis of bone marrow HSPCs from patients with myelodysplastic syndromes

STAR protocols, 2022-12, Vol.3 (4), p.101764-101764, Article 101764

2022

Volltextzugriff (PDF)

Hematopoietic stem cells with granulo-monocytic differentiation state overcome venetoclax sensitivity in patients with myelodysplastic syndromes

Nature communications, 2024-03, Vol.15 (1), p.2428-2428, Article 2428

2024

Volltextzugriff (PDF)

Transcriptomic analysis implicates necroptosis in disease progression and prognosis in myelodysplastic syndromes

Leukemia, 2020-03, Vol.34 (3), p.872-881

2020

Volltextzugriff (PDF)

Hematopoiesis under telomere attrition at the single-cell resolution

Nature communications, 2021-11, Vol.12 (1), p.6850-6850, Article 6850

2021

Volltextzugriff (PDF)

Agrobacterium VirE2 Protein Modulates Plant Gene Expression and Mediates Transformation From Its Location Outside the Nucleus

Frontiers in plant science, 2021-06, Vol.12, p.684192-684192

2021

Volltextzugriff (PDF)

S185: TARGETING DNA2 OVERCOMES METABOLIC REPROGRAMMING IN 1Q21 MULTIPLE MYELOMA

HemaSphere, 2023-08, Vol.7 (S3), p.e91269c8-n/a

2023

Volltextzugriff (PDF)

LILRB4 expression in chronic myelomonocytic leukemia and myelodysplastic syndrome based on response to hypomethylating agents

Leukemia & lymphoma, 2020-05, Vol.61 (6), p.1493-1499

2020

Volltextzugriff (PDF)

1 – 25 von 109

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(107)
Mit Volltextzugriff
(95)

Publikationsform

Artikel
(108)
Tagungsberichte
(1)

Sprache

Englisch
(107)
Japanisch
(11)
Russisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(47)
Life Sciences & Biomedicine
(36)
Humans
(31)
Hematology
(20)
Myelodysplastic Syndromes
(17)
Oncology
(17)
Myelodysplastic Syndromes - Genetics
(16)
Apoptosis
(11)
Leukemia
(11)
Hematopoietic Stem Cells
(9)
Myelodysplastic Syndrome
(9)
Exact Sciences And Technology
(8)
Myelodysplastic Syndromes - Drug Therapy
(8)
Myelodysplastic Syndromes - Pathology
(8)
Physical Sciences
(8)
Technology
(8)
Bone Marrow
(7)
Cell Biology
(7)
Chemistry
(7)
Chronic Myelomonocytic Leukemia
(7)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(36)
Applied Surface Science
(9)
Leukemia Research
(8)
Hemasphere
(5)
Leukemia
(5)
Clinical Lymphoma, Myeloma And Leukemia
(4)
Nature Communications
(3)
Nature Medicine
(3)
Plos One
(3)
Blood Advances
(2)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Global H3K4me3 genome mapping reveals alterations of innate immunity signaling and overexpression of JMJD3 in human myelodysplastic syndrome CD34+ cells

S160: MOLECULAR DETERMINANTS OF DISEASE PROGRESSION AFTER HYPOMETHYLATING AGENT THERAPY IN RAS PATHWAY MUTANT CHRONIC MYELOMONOCYTIC LEUKEMIA AT THE SINGLE‐CELL LEVEL

Toll-like receptor alterations in myelodysplastic syndrome

Identification of the Specific Hematopoietic Stem Cell Populations Responsible for Failure to Hypomethylating Agents in Myelodysplastic Syndromes

PS1325 IDENTIFICATION AND TARGETING OF MOLECULAR SIGNATURES OF HYPOMETHYLATING AGENT RESISTANCE IN MYELODYSPLASTIC SYNDROME AND CHRONIC MYELOMONOCYTIC LEUKEMIA

Deregulation of innate immune and inflammatory signaling in myelodysplastic syndromes

SINGLE CELL DATA

Topic: AS04-MDS Biology and Pathogenesis/AS04d-Somatic mutations

O04 - Topic: AS04-MDS Biology and Pathogenesis/AS04d-Somatic mutations: SINGLE-CELL-LEVEL ANALYSIS OF SF3B1-MUTANT MYELODYSPLASTIC SYNDROME WITH RINGED SIDEROBLASTS

Mechanisms of resistance to apoptosis in the human acute promyelocytic leukemia cell line NB4

52 - Identification of the Specific Hematopoietic Stem Cell Populations Responsible for Failure to Hypomethylating Agents in Myelodysplastic Syndromes

Changes in mitochondrial function induced by dequalinium precede oxidative stress and apoptosis in the human prostate-cancer cell line PC-3

Changes in mitochondrial function induced by dequalinium precede oxidative stress and apoptosis in the human prostate cancer cell line PC-3

ILF2 Is a Regulator of RNA Splicing and DNA Damage Response in 1q21-Amplified Multiple Myeloma

Isolation, culture, and immunophenotypic analysis of bone marrow HSPCs from patients with myelodysplastic syndromes

Hematopoietic stem cells with granulo-monocytic differentiation state overcome venetoclax sensitivity in patients with myelodysplastic syndromes

Transcriptomic analysis implicates necroptosis in disease progression and prognosis in myelodysplastic syndromes

Hematopoiesis under telomere attrition at the single-cell resolution

Targeting DNA2 overcomes metabolic reprogramming in multiple myeloma

Agrobacterium VirE2 Protein Modulates Plant Gene Expression and Mediates Transformation From Its Location Outside the Nucleus

S185: TARGETING DNA2 OVERCOMES METABOLIC REPROGRAMMING IN 1Q21 MULTIPLE MYELOMA

LILRB4 expression in chronic myelomonocytic leukemia and myelodysplastic syndrome based on response to hypomethylating agents

P723: CLINICAL AND MOLECULAR ASSOCIATIONS WITH OUTCOMES IN HIGHER RISK MYELODYSPLASTIC SYNDROMES TREATED WITH HYPOMETHYLATING AGENTS PLUS VENETOCLAX

P1330: CYTOREDUCTIVE CHEMOTHERAPY COULD ACCELERATE THE LOSS OF CLONAL DIVERSITY IN HEMATOPOIETIC STEM CELLS AND PROMOTES THE CONVERGENT EVOLUTION OF THERAPY‐RELATED CLONAL HEMATOPOIESIS

Suchergebnisse filtern